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a b s t r a c t
Mouse polyomavirus (MPyV) is considered a potential tool for the application of gene therapy; however,
the current knowledge of the encapsulation of DNA into virions is vague. We used a series of assays based
on the encapsidation of a reporter vector into MPyV pseudovirions to identify putative cis-acting
elements that are involved in DNA encapsidation. None of the sequences that were derived from MPyV
have been shown to solely enhance the encapsidation of a reporter vector in the assay. The frequency of
encapsidation strongly correlated with the total intracellular amount of the vector after transfection. The
encapsidation of target DNA into the pseudovirions was shown to be non-speciﬁc, and the packaging of
non-replicated DNA was observed. We propose that the actual concentration of target DNA at the sites of
virion formation is the primary factor that determines its selection for encapsidation.
& 2013 Elsevier Inc. All rights reserved.
Introduction
Mouse polyomavirus (MPyV) and simian virus 40 (SV40) have
historically served as molecular biology models and are considered
potential gene therapy tools in anticancer therapy. MPyV seems to be
superior for this type of application due to the absence of a pre-
existing immunity in the human population. Both viruses are mem-
bers of Polyomaviridae, which is a family of small, non-enveloped DNA
viruses. The approximately 5.3-kb genome of MPyV circular dsDNA
encodes three early regulatory proteins, designated small (ST), middle
(MT) and large (LT) tumor antigens, and three late structural proteins,
the viral proteins VP1, VP2 and VP3. Viral DNA is assembled with
histones of cellular origin (except H1) in the form of a minichromo-
some and is encapsidated into an icosahedral capsid approximately
45 nm in diameter. The capsid consists of 72 capsomers composed of
ﬁve monomers of the major capsid protein, VP1 and one of the minor
proteins (VP2 or VP3), which faces the internal cavity of the viral shell
(Chen et al., 1998). The processes of MPyV virion morphogenesis,
genome selection and its encapsidation, albeit important for gene
therapy vector design, are not well understood.
For SV40, detailed analyses of deletion mutants of the virus
were performed and have revealed that the cis-acting DNA signal,
which is important for the encapsidation of the SV40 minichro-
mosome, resides in the enhancer region close to the origin of
replication (ori) (Oppenheim et al., 1992; DalyotHerman et al.,
1996). The signal is called ses (SV40 encapsidation signal). The
recognition of the SV40 minichromosome during packaging is
thought to be achieved via Sp1, a mammalian transcription factor,
which binds ses within the regulatory region of the genome
(Gordon-Shaag et al., 2002). Sp1 recruits the capsid proteins to
the viral minichromosome by forming a recruitment complex that
is composed of the Sp1 transcription factor and the SV40 cap-
somere (which is formed by ﬁve molecules of VP1 and one
molecule of VP2 or VP3). Furthermore, the binding of the recruit-
ment complex to ses via the association of VP2/3 with Sp1 leads to
the repression of both early and late genes (Gordon-Shaag et al.,
1998), thus regulating the transition from replication and tran-
scription to assembly. Sp1 has not been found in mature virions
(Roitman-Shemer et al., 2007), which indicates that before assem-
bly, the transcription factor is displaced from the viral genome.
In contrast to SV40, the MPyV cis-acting signals and trans-
acting proteins, which are prerequisites for the encapsidation of its
DNA, have not been identiﬁed. The similarities in the organization
of the regulatory region of both viruses justify the presumption
that these elements exist and drive the virion assembly of MPyV.
For example, the transcriptional regulator Ying-Yang 1 (YY1),
which is a component of the nuclear matrix, has been found to
directly interact with the major capsid protein VP1 of MPyV
in vivo; however, the biological role of this interaction is not yet
understood (Palkova et al., 2000). Three YY1 binding sites are
present in the MPyV genome (Martelli et al., 1996, Gendron et al.,
1996), and the direct interaction of VP1-YY1 could offer the
possibility that YY1 can be involved in virion assembly similar to
Sp1 in SV40 morphogenesis.
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In this study, we attempted to identify the encapsidation signal
for MPyV. Instead of deleting the viral genome and screening for
the alleviation of genome packaging in mutants, we used methods
for the efﬁcient intracellular assembly of reporter vector (RV) DNA
into pseudovirions, which have been recently developed for both
SV40 (Oppenheim and Peleg, 1989) and papillomaviral vectors
(Buck et al., 2004). We introduced parts of the MPyV viral genome
in the target RVs to enhance their encapsidation. Moreover, by
using the SV40 regulatory elements for MPyV encapsidation, we
experimentally separated the process of encapsidation from MPyV
DNA replication.
Results
Design and construction of pseudovirion-based assays
Based on SV40 research (Oppenheim et al., 1992), we reasoned
that sequences around the origin of replication (ori) and the
enhancer have the highest probability of containing the encapsi-
dation sequence; however, we faced the problem that the impor-
tance of viral genome replication during virion assembly has never
been systematically analyzed. For MPyV, it has been convincingly
shown that the modiﬁcation of the enhancer region can have an
increased effect of one or two orders of magnitude on MPyV
compared to SV40 DNA replication (Guo and DePamphilis, 1992)
and that the manipulation of the viral genome in the YY1-binding
area dramatically reduces genome replication (Spanielová, 2002).
We assumed that the construction of an MPyV deletion mutant in
a regulatory region would likely lead to restricted replication,
decreased DNA copy number and limited encapsidation, regardless
of its intrinsic packaging potential. For this reason, we did not use
the deletion mutant approach, as performed during the identiﬁca-
tion of ses (Oppenheim et al., 1992). Instead, we developed several
assays based on pseudovirion technology. This technology allows
for the generation of pseudovirions consisting of capsid proteins
and an RV (instead of a viral genome) associated with cellular
histones in producer cells.
The ﬁrst assay, called the Reporter vector Encapsidation into
Pseudoivirions system (REPs) is designed to use the pseudovirions
for the subsequent experimental infection, which causes the
transduction of the reporter gene. The efﬁcacy of the pseudoinfec-
tion (transduction) by pseudovirions, which contain different RVs
(measured by the activity of the reporter gene product after the
gene transduction by each individual vector), then corresponds to
the efﬁcacy of their packaging. The RVs that carry the part of MPyV
with a putative encapsidation signal sequence would be trans-
duced with the highest frequency. Speciﬁcally, the system consists
of a series of RVs that serve as target DNAs for encapsidation,
helper vector(s) providing the capsid proteins in trans and two cell
lines: one allowing the production of pseudovirions (producer
cells) and the second (detection cells) allowing the sensitive
screening of reporter activity after pseudoinfection (transduction).
RVs were constructed from the pGL3-Control vector (Promega),
which harbors the luciferase reporter gene under the control of a
strong SV40 promoter. The vector also carries the SV40 enhancer
and SV40 ori, which ensures the replication in monkey and human
cell lines with the constitutive expression of the SV40 large T-
antigen. The plasmid pGL3-Control does not contain any MPyV-
derived sequences. The plasmid's size corresponds to the size of
the MPyV genome (5.3 kb); thus, it serves as the control RV
throughout the study. For the construction of RVs, the MPyV
genome was divided into nine 650-bp-long fragments that cover
the entire viral genome (Table 1), and each fragment was cloned
into the multiple cloning site of the shortened pGL3-Control
plasmid (pGL3-ΔC, see the section “Materials and methods”).
The ﬁnal size of all RVs was approximately the size of the MPyV
genome to allow the unrestrained encapsidation of constructs.
The helper vectors ph2-VP1 (encoding VP1 and VP2) and ph3β
(encoding VP3 and β-galactosidase) were constructed from codon-
optimized MPyV structural genes (see the section “Materials and
methods” for detail). Both helper vectors contain the SV40 origin
of replication, and their size exceeds the MPyV genome size by
2.5 kb to prevent their encapsidation. The β-galactosidase gene
was included in the system to normalize the transfection efﬁ-
ciency. In some experiments, the pCG-VP1/2/3 vector (6.5 kb)
that encoded all three structural proteins under the control of
the MPyV late promoter was used. The descriptions of all of
the plasmids that were used in the study are shown in the
Supplementary Table S2. Human embryonic kidney 293TT cells
that stably expressed the SV40 large T-antigen to enhance the
replication of SV40 origin-containing plasmids were used as
producer cells.
The second assay, called the qPCR assay, is derived from the
REPs system. During the qPCR assay, the RVs are isolated directly
from pseudovirions and are used for quantitative PCR (qPCR)
analysis to determine the most frequently encapsidated RV. This
assay eliminates the need to determine the efﬁcacy of packaging
by secondary transduction to the screening line, which can be a
potential confounding factor. Moreover, due to sequence-speciﬁc
detection of each RV, it allows direct identiﬁcation of RV from a
mixture of pseudovirions carrying different RVs. There is, however,
a potential disadvantage in that fragmented DNA, or DNA of less
than unit length, enclosed in so called “empty” capsids can be
detected.
The third assay, called the transformation assay, also directly
identiﬁes encapsidated RV, but the DNA extracted from pseudo-
virions is used for the transformation of bacteria. The identiﬁca-
tion of encapsidated RVs is based on the subsequent sequencing of
vectors isolated from bacterial colonies. In contrast to the qPCR
assay, this approach ensures the identiﬁcation of full-length intact
encapsidated vectors, thus further increasing the accuracy of the
experimental evaluation.
Pseudovirions are generated inside the cell nucleus
To ensure that MPyV pseudovirions can be successfully gener-
ated in cells using our system, we co-transfected 293TT producer
cells with helper plasmids, ph2-VP1, ph3β and the reporter control
vector, pGL3-Control. The transfection efﬁciency was evaluated by
immunoﬂuorescence. Capsid proteins and luciferase genes were
coexpressed in 87% of transfected cells (data not shown). At 48 h
post-transfection, cells were collected and were then either sub-
jected to a puriﬁcation procedure or processed directly for electron
microscopic examination on ultrathin sections in order to exclude
a theoretical possibility that transducing particles are nonspeciﬁ-
cally formed in the cell lysate through a self-assembly process.
Table 1
Description of MPyV regions in reporter vectors.
Reporter vector Region location (nucleotides)a Landmarks
RV-1 4953–311 Regulatory region
RV-2 292–985 LT/MT/ST, intron
RV-3 971–1635 LT/MT
RV-4 1618–2180 LT
RV-5 2172–2836 LT
RV-6 2816–3496 poly(A) signal, VP1
RV-7 3479–4137 VP1
RV-8 4104–4741 VP2, VP3
RV-9 4748–3 VP2, enhancer
a MPyV genome numbering according to the GenBank database.
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Electron microscopy conﬁrmed that viral particles could be pur-
iﬁed from cell extracts (Fig. 1A) and that the cell-associated viral
particles could be detected inside the nuclei of transfected cells
(Fig. 1B).
A region of early introns (nucleotides 292–985) in the MPyV genome
surpasses other regions in the REPs assay
The REPs assay was designed as a rapid screen for packaging
signal. The pseudovirions, which were formed after the transfec-
tion of producer cells with helper vectors and with each individual
target RV, were not puriﬁed, but the whole-cell lysate that was
treated with DNase I was used for the transduction of the
detection cell line. In this way, the efﬁciency of the encapsidation
of a given RV in producer cells can be estimated from the
normalized activity of luciferase that was measured in the corre-
sponding cell extract from transduced detection cells. Initially,
MPyV-permissive mouse 3T6 ﬁbroblasts were used as the detec-
tion cell line. Using these cells, we failed to detect any luciferase
activity in the REPs assay (data not shown). However, high
luciferase activity was achieved in COS-1 cells after the transduc-
tion of pGL3-Control. COS-1 cells that express the SV40 large T-
antigen support the replication of plasmids containing the ori. We
concluded that (i) the replication of the RV in detection cell lines is
necessary to increase the sensitivity of the assay and (ii) RVs can
Fig. 1. Electron micrographs of MPyV viral particles that were produced in 293TT cells. (A) Puriﬁed viral particles were visualized by negative staining. (B) For transmission
electron microscopy on ultrathin (70 nm) resin sections, cells were ﬁxed at 48 h post-transfection. Particles were observed in clusters (as shown in the inset) inside the
nucleus in the periphery of the condensed chromatin (Chr). Cyt, cytoplasm.
Fig. 2. The REPs assay in COS-1 cells. The 293TT cell line was co-transfected with the helper vectors ph2-VP1 and ph3β and each of the indicated RVs. A cell lysate from the
production cell line was used for the transduction of the COS-1 cell line. Luciferase activity was measured in cell lysates that were prepared at 48 h post-transfection and in
lysates that were prepared at 48 h post-transduction. Relative luciferase activity was determined for each cell lysate as described in the section Materials and methods, and
the ﬁnal relative luciferase activity was calculated by dividing the relative luciferase activity that was determined in COS-1 cell lysates with the relative luciferase activity that
was determined in the corresponding 293TT cell lysates. The graph shows the results of three independent experiments, and the relative luciferase activity that was
calculated for each sample is expressed as a percentage of the relative luciferase activity that was determined for the pGL3-Control (C) vector (represented by 100% on
x-axis). The standard deviations of the mean are indicated by error bars.
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be effectively transduced by MPyV pseudovirions. Finally, the COS-
1 cell line was employed as a detection cell line in REPs assays.
The results from three separate REPs assay screens are shown
in Fig. 2. Out of all RVs, reporter vector 2 (RV-2) was the only
vector that was transduced into the COS-1 cell line more efﬁciently
than the control vector. This observation suggested that the RV-2
MPyV genome region (nucleotides 292–985) could enhance the
packaging of DNA by MPyV capsids. However, we noted that the
transfection of RV-2 always resulted in the highest luciferase
activity in producer cells (data not shown). This result may
indicate that this MPyV region can convey another quality, such
as replication enhancement or plasmid stability, instead of the
putative packaging signal. Although this bias was corrected by
normalizing the results using β-galactosidase activity in cell
lysates used for transduction, the bias could not be avoided during
the ﬁnal screen in the detection cell line that supported replica-
tion. For this reason, we decided to verify the data by an
independent method and to focus on RV-2 and its unique qualities.
None of the MPyV regions are required for the encapsidation of the
reporter vector into the pseudovirions
We decided to trace encapsidated RVs directly in assembled
pseudovirions by qPCR assay. We mixed all RVs (including the
pGL3-Control) together with helper vectors (ph2-VP1 and ph3β),
transfected the entire mixture into the 293TT producer cells and
separately analyzed the DNA contents of the pseudovirions and the
total extrachromosomal DNA in transfected cells. The transfected
producer cells were harvested at 48 h post-transfection and divided;
one-half was used for the extraction of total extrachromosomal DNA
(by a modiﬁed Hirt method), and the second half was used for the
extraction of nuclease-resistant (encapsidated) DNA. Both samples
were used for qPCR with primers that were speciﬁc for each RV. The
encapsidation efﬁciency for each RV was determined as the ratio of
the amount of the RV that was detected in the nuclease-resistant pool
and in the total extrachromosomal DNA. In two separate experi-
ments, none of the MPyV regions were able to signiﬁcantly increase
the encapsidation efﬁciency of any RV over the control vector
(Fig. 3B). Surprisingly, RV-1, which possessed a complete set of MPyV
regulatory elements that included the MPyV ori, repeatedly exhibited
the lowest calculated encapsidation efﬁciency (approximately 40% of
the control). This result reﬂects the fact that the amount of RV-1
reached only the median value in the nuclease-resistant (encapsi-
dated) pool of DNA; whereas its proportion in the total extrachro-
mosomal DNA sample was above the mean of vector amounts
(Fig. 3A). RV-2 that positively scored in the REPs assays was over-
represented in both DNA samples (Fig. 3B), but the nuclease-
resistant-to-total DNA proportion was similar to the control vector.
Altogether, the results shown in Fig. 3 suggest that the RV packaging
in this experimental system is not enhanced by any distinct MPyV
element and that the second MPyV ori region in RV-1 can even
negatively inﬂuence encapsidation. This result also suggests that the
presence of the SV40 ori and ses in all RVs may drive the replication
and/or packaging, overcome the putative MPyV encapsidation signal-
ing and limit the usage of this experimental design. To dissect the role
of these elements in vector packaging, we performed additional
experiments in a mouse production cell line.
Fig. 3. The determination of reporter vector encapsidation efﬁciency by qPCR. All 10 RVs (including pGL3-Control) were mixed together with helper vectors ph2-VP1 and
ph3β and were transfected into the 293TT cell line. Cells were harvested at 48 h post-transfection. The total extrachromosomal DNA and nuclease-resistant DNA were
extracted separately from equivalent numbers of cells. Both DNA samples were used for qPCR with primers that were speciﬁc for each RV to determine the amount of each
RV. The data were normalized to the luciferase gene to calculate the relative amount of each RV in both DNA pools. (A) The relative amounts of each RV in the
extrachromosomal (Total) and nuclease-resistant (Encapsidated) DNA samples are shown for two independent experiments as the means of triplicate samples7standard
deviations (error bars). (B) The encapsidation efﬁciency was determined from the data that are shown in (A) as a ratio between the relative amounts of each RV that were
detected in the nuclease-resistant pool and in the total extrachromosomal DNA. The data are plotted as percentages of encapsidation efﬁciencies compared to the control
(C) RV (set as 100%). Error bars represent the standard deviations of triplicate samples.
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Reporter vectors can be encapsidated into MPyV pseudovirions
without replication
To separate the driving force of SV40-based replication and the
possible inﬂuence of ses on encapsidation, we performed additional
experiments in WOP cells. The WOP cell line is a mouse cell line
expressing MPyV T-antigens, which support the replication of plas-
mids containing the MPyV ori and therefore only RV-1 out of all of
the RVs is able to replicate in these cells. Originally, we attempted to
produce MPyV pseudovirions using the same reporter and helper
vectors as in the REPs assay. However, when the expression of the
capsid and reporter genes after co-transfection was assessed using
immunoﬂuorescence, we discovered that the co-transfection/expres-
sion rate was low in these particular cells (less than 10% of transfected
cells expressed luciferase together with all three capsid proteins; data
not shown). For this reason, further experiments were performed with
the pCG-VP1/2/3 vector, which ensured the weak, but simultaneous,
expression of all three capsid genes in one cell. Moreover, the mouse
producer cells allowed us to use the MPyV genomic DNA as the helper
vector for the production of high levels of all capsid proteins.
Pseudovirions generated in WOP cells were further analyzed by
transformation assay: the encapsidated plasmids that were extracted
as nuclease-resistant DNA were used for the transformation of
Escherichia coli. To reveal their identity, the RVs were isolated from
ampicillin-resistant colonies and then sequenced.
In the initial experiment, we used an equimolar mix of all RVs
(including the pGL3-Control) as the target DNA to determine
whether any RVs would show preferential encapsidation. In the
second set of experiments, only the pGFPmax vector served as the
target DNA. The vector pGFPmax does not contain any sequences
that were derived from either MPyV or the SV40 genome and has a
suitable size (3.8 kb) for encapsidation. Using this target vector, we
wanted to determine whether a non-replicating vector without ses
and MPyV sequences could be successfully encapsidated. Target
vectors were used for transfections with either MPyV DNA or pCG-
VP1/2/3 as the helper vector (Table 2). Control transfections without
the helper vector were also performed (see Table 2). Cells were
harvested at 48 h post-transfection, and total extrachromosomal and
nuclease-resistant DNAs were extracted from an equivalent number
of cells and were used for qPCR quantiﬁcation and E. coli transforma-
tion, respectively. The overall results of this assay, which were
expressed as numbers of E. coli colonies grown after transformation
with each sample, are shown in Table 2. The transformation of DNA
that was extracted from pseudovirions formed with the use of MPyV
DNA as the helper vector led to the emergence of 26 colonies;
whereas the pCG-VP1/2/3 vector co-transfection samples yielded 166
colonies. Notably, in contrast to pCG-VP1/2/3, MPyV DNA could
compete with the encapsidation of RVs, and the low colony yield
was expected. The control reaction without the transfected helper
vector yielded no colonies, indicating that the nuclease treatment
was effective. Subsequently, plasmid DNA from 52 colonies (all
colonies from the MPyV DNA sample and 26 randomly chosen
colonies grown from the pCG-VP1/2/3 sample) was extracted and
sequenced. In parallel, the total extrachromosomal DNA that was
extracted from the same samples of transfected cells was subjected
to qPCR to determine the total amount of each individual RV. The
frequency of each RV that was found in the nuclease-resistant pool
and its proportion relative to the total amount of each vector in the
extrachromosomal DNA are shown in Table 3. The data from the
sample in which MPyV DNA served as a helper indicate that the high
total amount of RV-2 in the transfected cells led to its preferential
encapsidation. In contrast, the ampliﬁcation of RV-1 was likely
negatively inﬂuenced by the presence of the replicating viral
genome, thus decreasing the probability of its encapsidation. How-
ever, sequence analysis of 26 clones from randomly chosen colonies
that were obtained from the sample in which the pCG-VP1/2/3
vector served as a helper revealed that RV-1 had been encapsidated
with the highest frequency. The high total amount of RV-1 in the
extrachromosomal DNA fraction also indicated that its replication
was not inﬂuenced by the pCG-VP1/2/3 helper DNA (as observed for
MPyV helper DNA; see Table 3). Although it is impossible to
determine the encapsidation efﬁciency for each vector because of
the low number of sequenced clones, the data suggest that encapsi-
dation in the mouse production system does not exhibit a strict
sequence preference and reﬂects the RV amount. Spearman's rank
correlation test (Wessa, 2012) conﬁrmed a very strong positive
correlation [ρ(8)¼0.852, p¼0.001] between the amount and fre-
quency of encapsidation of a given RV in the MPyV DNA helper
sample and a strong positive correlation [ρ(8)¼0.705, p¼0.023] in
the pCG-VP1/2/3 helper sample, which was statistically signiﬁcant.
Moreover, a second set of experiments with the pGFPmax vector as a
target DNA (Table 2) was performed to reveal whether the SV40
encapsidation signal is dispensable for packaging. The numbers of
colonies that are shown in Table 2 indicate that the pGFPmax vector,
which lacks SV40 elements, could be efﬁciently encapsidated into the
viral particles. Taken together, these results suggest that the vector
amount is the only important factor in encapsidation and
that replication competence, which is connected with the presence
of SV40 and MPyV regulatory elements, is not necessary for
encapsidation.
Some regions of the MPyV genome enhance the stability of DNA after
transfection
Finally, we focused on RV-2 and its unique qualities that led to
its positive scoring in the REPs assay (Fig. 2) and partly in the
Table 2
Summary of transfections performed in WOP cells for the extraction of nuclease-
resistant DNA used for E. coli transformation.
Vector Transfection mix
Helper MPyV DNA þ   þ  
pCG-VP1/2/3  þ   þ 
Target RVs mixa þ þ þ   
pGFP max    þ þ þ
No. of colonies Expt. 1 26b 166c 0 81 146 0
Expt. 2 ND ND ND 65 67 0
a Equimolar ratios of all RVs were used in the transfection.
b All colonies were used for sequencing.
c 26 colonies were randomly chosen for sequencing; ND – not done.
Table 3
Encapsidation as determined from transformation assays.
Helper: MPyV DNA Helper: pCG-VP1/2/3
No. of
coloniesa
Relative
amountb
No. of
coloniesa
Relative
amountb
RV-1 0 0.10 19 0.25
RV-2 11 0.23 2 0.17
RV-3 0 0.02 0 0.01
RV-4 1 0.11 0 0.10
RV-5 4 0.13 1 0.11
RV-6 0 0.06 2 0.09
RV-7 3 0.07 0 0.08
RV-8 0 0.03 0 0.03
RV-9 3 0.10 1 0.05
Control 4 0.15 1 0.10
Total 26 1 26 1
a Number of colonies that contain a given RV.
b The relative amount of each RV in the sample was determined by qPCR.
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transformation assay (Table 2). We repeatedly observed that,
compared with other RVs, the direct transfection of RV-2 into
cells leads to very high luciferase activity in all cell lines tested
(NIH-3T3, 3T6, COS-1, 293TT and WOP cells, data not shown). Our
results from qPCR (Fig. 3B) also suggested that this effect was more
likely caused by an augmented amount of the vector than by the
transcriptional upregulation of the activity of the reporter gene
in transfected cells. To examine whether the early intron region
(nucleotides 292–985) of the MPyV genome can confer some
unusual property on RV-2 that leads to the stabilization of the
plasmid (due to the plasmid maintenance sequences) or to ori-
independent replication, we transfected individual RVs into the
mouse NIH-3T3 cell line and followed the reporter activity in
several generations of cells. The NIH-3T3 cell line is a parental line
for WOP cells and does not normally support the replication of
MPyV ori-containing plasmids without the presence of large T-
antigen. After the transfection of a full set of RVs into this cell line,
RV-2 exhibited the highest luciferase activity, even after three cell
passages (data not shown). We performed a replication assay to
exclude the possibility that an ori-independent, low level of
plasmid replication, which is occasionally observed (Katinka and
Yaniv, 1983), is responsible for this effect. The total DNA from cells
that were transfected by nucleofection was extracted, digested
with Dpn I and analyzed by gel electrophoresis and Southern
blotting. Dpn I is a methylation-sensitive enzyme; newly repli-
cated DNA molecules are resistant to Dpn I digestion. The results
showed that none of the RVs could be replicated in 3T3 cells
(Fig. 4; note complete digestion by Dpn I). More importantly, a
great difference in the abundance of individual plasmids was
noted, although the transfection was performed with equal
amounts of RVs. Because the Amaxa Nucleofector Technology is
considered the most reproducible method of transfection, the
results suggest that RV-2, RV-1 and RV-4 harbor MPyV elements
that are responsible for the increased intracellular stability of DNA
after transfection. RV-2 was the most stable (Fig. 4).
Discussion
In this study, we attempted to identify the MPyV encapsidation
signal. We used pseudovirion-based approaches for the identiﬁca-
tion of the polyomavirus-speciﬁc sequences that enhance the
encapsidation of RVs.
From the series of assays, only the most laborious, transforma-
tion assay led to the ﬁnal conclusion that the encapsidation of
target DNA is not driven by any distinct, sequence-speciﬁc encap-
sidation signal. The assay conﬁrmed a strong positive correlation
between the amount and frequency of encapsidation of a given RV.
Moreover, we used two different helpers (pCG-VP1/2/3 or MPyV
DNA) for the production of pseudovirions in WOP cells and both
variants brought additional interesting results. The presence of the
MPyV DNA as a replicating and transcriptionally active viral
genome creates a highly competitive environment in the system.
This environment probably negatively affected RV-1 replication
because its relative intracellular amount was lower than expected
for a vector with an exclusive capacity to replicate. It is well-
documented that the presence of wild-type replicons strongly
interferes with mutant replication after transfection (Nilsson et al.,
1991) and the defect could be at the stage of initiation (Yamaguchi
and DePamphilis, 1986). Furthermore, MPyV DNA is undoubtedly
efﬁciently encapsidated into virions but cannot be detected by this
type of assay. Therefore, the RVs that were identiﬁed with a
frequency that was related to their intracellular amounts reﬂect
the minority of successfully encapsulated DNA. In contrast, the
encapsidation of pCG-VP1/2/3 is prevented due to a size discrimi-
nation mechanism, and the vector did not restrict the replication
potential of RV-1, which accumulated in the system. Subsequently,
the high relative amount of RV-1 led to its preferential encapsida-
tion. However, in both cases, the non-replicating pGFPmax vector
without any viral (MPyV or SV40) sequence could be encapsidated
equally well. The results indicated that an intracellular amount of
target DNA determines the outcome of the encapsidation process,
and virtually any DNA with an appropriate size can be encapsi-
dated. The preferential packaging of a RV with an active regulatory
region can be a consequence of the fact that encapsidation is likely
interconnected with the processes of replication and/or transcrip-
tion. According to our observations, at the early stages of the late
phase of MPyV infection, the newly expressed VP1 protein
accumulates at distinct sites of DNA replication near PML bodies;
whereas during the later times, the VP1 protein expands through-
out the nucleus (Ryabchenko, unpublished data). Therefore, the
organization of the replication foci during the initial phases of
virion formation, when capsid proteins are spare, can favor DNA
with a highly active ori region for encapsidation. In agreement
with this notion, in our mouse production system, where the pCG-
VP1/2/3 vector ensures a low level of capsid proteins (thus
reminiscent of early events in the late phase of infection), RV-1
containing an active ori was detected as an almost exclusive target
of encapsidation (Table 3). In contrast, MPyV helper DNA played a
dual role in the mouse system by encapsidating itself as replicating
target DNA in the initial phase of virion formation and ensuring
high levels of capsid proteins later, thus allowing the encapsida-
tion of other available targets. We propose that by employing such
a simple regulation of encapsidation that is based on the spatio-
temporal organization of virion formation, MPyV can achieve a
reasonable level of encapsidation speciﬁcity without employing a
sequence-speciﬁc signal.
The results from the qPCR assay were also in agreement with
this notion. None of the MPyV sequences were able to enhance the
encapsidation of RVs and the RV-1 with second MPyV ori region
was packaged with the lowest efﬁciency. It has been shown that
SV40 LT can efﬁciently bind the MPyV ori on LT-binding sites
(Bhattacharyya et al., 1995) without triggering DNA replication.
We reasoned that SV40 LT binding on a non-active MPyV ori could
cause the retention of target DNA on chromatin and limit its
encapsidation.
The REPs system, originally designed as an easy and rapid
screening method, was unfortunately biased as a result of unex-
pected obstacles. The idea of the REPs system is based on the
Fig. 4. Determination of the intracellular amounts of reporter vectors. 3T3 cells
were transfected with individual RVs. The total extrachromosomal DNA was
extracted at 48 h post-transfection and was digested with Sal I and Dpn I enzymes.
DNA from each sample (0.5 μg) was separated using agarose electrophoresis,
subjected to Southern blotting, hybridized to a DIG-labeled luciferase gene probe,
detected with chemiluminescence and recorded by exposure to X-ray ﬁlm. The
optical density of the prominent band (indicated by an asterisk) was determined
with a densitometer and is shown in the upper row for each sample.
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assumption that intracellular levels of each RV in producer cells
are comparable due to the similar efﬁciency of replication driven
from a common SV40 origin. Normalizing the transfection efﬁ-
ciency of the system by the co-transfected internal control gene
(for β-galactosidase) and by the protein content in the lysate of the
producer cell should provide adequate corrections for perturba-
tions during the transduction assay. An analysis of the REPs
screening hit (RV-2) revealed that this is not the case. The
experiments that took into consideration the levels of copies of
individual RVs showed a constant and high level of RV-2 in cells,
and consequently, in viral particles in most assays (see Fig. 3B;
Table 3). By performing the replication assay with RVs that were
transfected into 3T3 cells, we excluded the possibility that the
plasmids undergo an ori-independent replication; however, with-
out further analyzing the reasons, we observed completely differ-
ent intracellular amounts of each RV after transfection. It has
previously been shown that the use of a second reporter plasmid
as an internal standard to normalize luciferase activity in transient
transfection experiments may lead to a systematic error due to the
interaction between co-transfected RVs (Huszár et al., 2001,
Bergeron et al., 1995). Moreover, it has been shown that coexpres-
sion efﬁciencies among transfected cells are variable, and a
signiﬁcant number of transfected cells express only a single target
protein (Ma et al., 2007). This observation points to the difﬁculties
that are connected with the comparison of the quantitative data
from parallel transfections in general; however, in our system, the
small error in the normalization of the cell lysates of producer cells
can be dramatically ampliﬁed during the ﬁnal screen in the
detection cell line where the RV replicates. We concluded that
this ampliﬁcation was the case for RV-2 in the REPs assay.
Until now, the SV40 ses sequence has been the only identiﬁed
encapsidation signal in polyomaviruses. Our work surprisingly
suggests the fact that the mechanism of the selection of DNA for
encapsidation may not be universal within the virus family. We
hypothesize that the mechanisms of encapsidation in MPyV and
SV40 may likely differ due to the differences in the DNA-binding
properties of the minor capsid proteins. The minor proteins of
SV40 bind nonspeciﬁcally to DNA (Dean et al., 1995), and Sp1
proteins cooperate in ses-speciﬁc DNA binding with VP2/3
(Gordon-Shaag et al., 2002); whereas MPyV VP2 and VP3 proteins
do not bind the DNA (Chang et al., 1993) None of these proteins
interact with the MPyV genome in virions (Carbone et al., 2004).
However, it should be noted that the SV40 mutant that lacked
minor structural proteins is able to encapsidate virus DNA efﬁ-
ciently (Nakanishi et al., 2007), which is similar to the correspond-
ing MPyV mutants (Mannova et al., 2002). Moreover, in vitro
experiments have shown that the ses sequence itself, in the
absence of a large excess of cellular chromatin, does not promote
the preferential binding of capsomere VP1(5)VP2/3 complexes to
the SV40 genome (Roitman-Shemer et al., 2007). These observa-
tions not only suggest that the involvement of these proteins in
the encapsidation process may differ between both viruses but
also that their importance may depend on the actual context.
Further investigation would be needed to evaluate the preferential
mode of genome selection during virion assembly for other
members of the Polyomaviridae family.
Materials and methods
Plasmids and viruses
For the construction of RVs, the plasmid pGL3-Control (Pro-
mega, Madison, Wisconsin, USA) was shortened by digestion with
the restriction enzyme Ssp I and re-ligation (without the f1 ori
sequence). The obtained pGL3-ΔC vector could accommodate
polyomaviral sequences without exceeding the size of the MPyV
genome. Both vectors, pGL3-Control and pGL3-ΔC, yielded the
same level of activity of the reporter luciferase gene that they
carried. The genome of the MPyV BG strain (GenBank:
AF442959.1) was divided into nine regions of approximately 650
bp each, and each region was cloned using the In-Fusion HD
Cloning System (Clontech Laboratories, Mountain View, California,
USA) into the Mlu I and Xho I sites of the pGL3-ΔC plasmid. All
clones were veriﬁed by sequencing. A list of the cloning primers
used is available as Supplementary information in Table S1.
The helper vector ph2-VP1 (7802 bp), which carries the codon-
modiﬁed VP1 and VP2 MPyV genes as described in Tolstov et al.
(2009), was constructed from the ph2p vector (Addgene plasmid
22520) (Pastrana et al., 2009) by digestion with the restriction
enzymes Stu I and Cla I and re-ligation with the PCR-ampliﬁed
product, which contains the human elongation factor-1 alpha
(hEF1a) promoter, codon-modiﬁed VP1 gene, woodchuck hepatitis
virus posttranscriptional regulatory element (WPRE) sequence and
hEF1a poly(A) signal from the pwP vector (Addgene plasmid
22519) (Pastrana et al., 2009). The vector ph3β (7538 bp), which
carries the codon-modiﬁed MPyV VP3 and β-galactosidase genes,
was constructed from ph3p (Addgene plasmid 22521) (Pastrana
et al., 2009) by digestion with the restriction enzymes Stu I and
Not I and re-ligation with the β-galactosidase gene, which was
obtained via Sma I and Not I digestion of the pCMVβ vector
(Clontech Laboratories, Mountain View, California, USA). The
vector pCG-VP1/2/3 (6542 bp) was constructed from the pGL3-
Control vector by the excision of the luciferase gene using Ehe I
and Xba I restriction enzymes and re-ligation with a part of the
polyomavirus genome that is composed of the regulatory and late-
gene regions (cut by Ehe I and Xba I from MPyV genome DNA).
The plasmid pmaxGFP (Lonza, Cologne, Germany), which encodes
maxGFP, which is a green ﬂuorescent protein from the copepod
Pontellina plumata, was used as a negative control vector in the
transfections and as a target DNA for some packaging experiments.
The plasmid pcDNA3-LT was used for the expression of the MPyV
LT antigen in some co-transfection experiments. The summarized
description of all plasmids that were used for the production of
the pseudovirion is shown in supplementary Table S2.
Cell lines and transfections
Mouse Swiss albino 3T6, NIH 3T3 mouse ﬁbroblasts, SV40-
transformed African green monkey kidney cells, COS-1 and WOP
cells were maintained in Dulbecco's modiﬁed Eagle medium
(DMEM) (Sigma-Aldrich, St. Louis, Missouri, USA) that was sup-
plemented with 10% Gibco™ fetal calf serum (Invitrogen, Paisley,
UK) and GlutaMAX™ (Invitrogen, Paisley, UK) at 37 1C in a 5% CO2-
air humidiﬁed incubator. The mouse WOP cell line that constitu-
tively expresses the MPyV large T-antigen is a 3T3 ﬁbroblast
derivative that was transformed using an origin-defective poly-
omavirus (Dailey and Basilico, 1985). The human embryonic
kidney cells 293TT that express the SV40 large T-antigen were
kindly provided by John Schiller and Chris Buck (Bethesda, Mary-
land, USA) and were cultivated as previously described (Buck and
Thompson, 2007).
The plasmid DNA that was used for transfections was puriﬁed
using either the EndoFree Plasmid Maxi Kit (Qiagen, Valencia,
California, USA) or the GenBond Plasmid Endofree FlexSpin Kit
(Renogen Biolab, Vancouver, Canada). 293TT or COS-1 cells were
transfected using the TurboFect Transfection Reagent (Thermo
Fisher Scientiﬁc, Waltham, Massachusetts, USA) according to the
manufacturers' instructions. Brieﬂy, logarithmically growing cells
(5105) in 6-well dishes were transfected with 4 μg of DNA. In
the REPs assay, 1.5 μg of ph2-VP1 and 0.5 μg of ph3β together with
2 μg of RV were transfected in a production cell line. WOP cells
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(for transformation assays) and 3T3 cells (for the replication assay)
(both 4106) were transfected (using Amaxas Nucleofectors
Technology [Lonza, Cologne, Germany] according to the manufac-
turer's instructions) with 6 μg of DNA (total) in solution V using
the programs U-030 and T-030, respectively. Speciﬁcally, the
mixed transfections (all RVs with helper DNA) contained either
2.5 μg of ph2VP1 and 0.5 μg of ph3β or 3 μg of pCG-VP1/2/3 as
helper DNA and 0.3 μg of each RV. For the comparative analysis of
the encapsidation of the pGFPmax vector, either 3 μg of MPyV
DNA or 3 μg of pCG-VP1/2/3 were mixed with 3 μg of the
pGFPmax plasmid and were transfected into WOP cells.
Pseudovirion production and puriﬁcation
Transfected 293TT cells were harvested 48 h post-transfection,
and pseudovirions were isolated by three rounds of freeze–thaw
cycles as described for polyomavirus (Türler and Beard, 1985),
concentrated by pelleting through a 10% sucrose cushion (25,000
r.p.m., Beckman SW28 rotor, 3 h, 4 1C), resuspended in B buffer
(150 mM NaCl, 10 mM Tris–HCl [pH 7.4], 0.01 mM CaCl2) and
puriﬁed by CsCl gradient ultracentrifugation (Beckman SW41
rotor, 35,000 r.p.m., 24 h, 18 1C). Gradient fractions were collected
by bottom puncture and were assayed for the presence of the VP1
protein by dot-blot analysis. The fractions that contained a peak
amount of VP1 (1.33–1.29 g/cm3) were dialyzed against B buffer,
concentrated by pelleting through a 10% sucrose cushion (Beck-
man SW41 rotor, 35,000 r.p.m., 2 h, 4 1C) and subjected to electron
microscopic examination.
REPs (transduction) assay
Producer 293TT cells (1.5106) were harvested at 48 h post-
transfection, washed by PBS and lysed in 100 μl of 250 mM Tris–
HCl [pH 7.4] by three rounds of freeze–thaw cycles. Lysates were
centrifuged at 10,000g for 5 min at 4 1C. The supernatant (50 μl)
was supplemented with magnesium chloride (ﬁnal concentration
10 mM), treated with 0.1 mg/ml DNase I (Roche Diagnostics
GmbH, Mannheim, Germany) for 30 min in 25 1C and used for
transduction. An aliquot of the original supernatant (20 μl) was
used for the parallel determination of the activity of luciferase and
β-galactosidase with the Dual-Light System (Applied Biosystems,
Bedford, Massachusetts, USA) and for the measurement of the
protein concentration (Bradford, 1976). Several cell lines were
tested as suitable detection cell lines; COS-1 cells were chosen
for the ﬁnal transduction screen. Exponentially growing COS-1
cells in a 6-well dish (1.5105 cells/well) were washed with 2 ml
of serum-free medium, and 50 μl of the lysate supernatant was
diluted in 150 μl of serum-free medium, added to cells and
incubated for 1.5 h in a thermostat with intermittent agitation.
At the end of the incubation, 2.5 ml of complete medium was
added to the cells. Transduced COS-1 cells were harvested at 48 h
post-transduction and were washed two times with phosphate-
buffered saline (PBS). The cell lysate was prepared by three rounds
of freeze–thaw cycles, and cellular debris was removed by cen-
trifugation at 14,000g and 4 1C for 5 min. Supernatants were used
for protein concentration (Bradford, 1976) and luciferase measure-
ment determinations with the Luciferase Assay System (Promega,
Madison, Wisconsin, USA) in a Microlite TLX2 luminometer
(Dynatech Laboratories, Inc, Chantilly, Virginia, USA). The trans-
duction efﬁcacy, which was expressed as relative luciferase activity
(in relative luminescence units) for each sample, was calculated
by dividing the relative activity of luciferase that was measured
in COS-1 cell lysates by the relative activity of luciferase that was
measured in the 2932TT cell lysate. The luciferase activities that
were measured in the 2932TT cell lysate were normalized by
protein concentrations and β-galactosidase activity (i.e., the
relative activity of luciferase in 293TT cells), and the luciferase
activities that were measured in COS-1 cells were normalized by
protein concentrations only (i.e., the relative activity of luciferase
in COS-1 cells). The background activity of luciferase that was
measured in the control sample that was transduced with lysates,
which were generated from 293TT cells that were transfected with
pGL3-Control vector without helper vectors, was subtracted from
all measurements before computation.
DNA analysis
Low-molecular-weight (extrachromosomal) DNA was extracted
from onemillion cells using a previously reported neutral lysis method
(Arad, 1998). The extraction of nuclease-resistant extrachromosomal
DNA from transfected cells was performed exactly as described in
(Buck et al., 2004). The viral genomic DNA that was used as helper in
transfection assays was extracted according to the classical Hirt
procedure (Hirt, 1967). For Southern blot analysis, the puriﬁcation of
total DNA from transfected cells was performed using a DNeasy Blood
& Tissue Kit (Qiagen, Valencia, California, USA).
Transformation assay
WOP cells that were transfected with mixed vectors (all RVs
and helper DNA) were harvested at 48 h post-transfection; ali-
quots were then generated by dividing each lysate in half. The
extrachromosomal and nuclease-resistant (encapsidated) DNAs
were extracted from each aliquot as described above. The
nuclease-resistant DNAwas used to transform Stellar™ Competent
Cells (E. coli HST08 strain) (Clontech Laboratories, Mountain View,
California, USA). The plasmid DNA from transformed bacterial
colonies was extracted using a QIAGEN Plasmid Mini Kit (Qiagen,
Valencia, California, USA) and was sequenced with a 3130xl
Genetic Analyzer (Applied Biosystems, Bedford, Massachusetts,
USA). Extrachromosomal DNA was used for quantitative polymer-
ase chain reaction (qPCR) analysis to determine the total intracel-
lular amounts of each individual RV in WOP cells. For the analysis
of the encapsidation of the pGFPmax vector, Stellar™ Competent
Cells were transformed with the nuclease-resistant DNAs. Equal
amounts of the bacterial suspension were plated on agar plates
containing kanamycin and ampicillin to discriminate between
pGFPmax (kanamycin resistance) and the helper vector (ampicillin
resistance).
Electron microscopy
For the ultrastructural analysis of cell-associated viral particles,
the producer cells were washed with PBS at 48 h post-transfection
and were ﬁxed with 3% glutaraldehyde in 0.1 M cacodylate buffer
on ice for 60 min. Cells were washed two times with cacodylate
buffer and were postﬁxed with 1% osmium tetroxide for 60 min.
The postﬁxation was followed by embedding the cells in 3% low
melting point agarose. The solidiﬁed agarose blocks were cut into
1 mm3 pieces and were dehydrated with an increasing ethanol
series (30%, 50%, 70%, 90%, 96%, 100% and 100%), each for 15 min.
Dehydrated blocks were inﬁltrated with an increasing series of
AGAR 100 resin (Gröpl, Tulln, Austria) in propylene oxide (propy-
lene oxide: AGAR 100-2 pure propylene oxide 10 min); 2:1
(15 min); 1:1 (30 min); 2:1 (30 min); and pure AGAR 100 over-
night; pure AGAR 100 (3 h). Polymerization was performed at
60 1C for 72 h. Sections of 70-nm thickness (Leica ultramicrotome
EM UC7, Leica Microsystems, Austria) were contrasted with a
saturated water solution of uranyl acetate (5 min) and Reynolds
lead citrate solution (3 min).
For the negative staining of puriﬁed viral particles, the parlodion-
carbon coated grids, which were activated by glow discharge, were put
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on the top of a 10 μl-drop of sample and were allowed to adsorb for
5 min; the grids were then rinsed in 2 drops of ﬁltered distilled water
and transferred onto 2 drops of 2% phosphotungstic acid (pH 7.3), left
for 1 min and then dried.
Electron micrographs were recorded in a JEM-1011 electron
microscope (JEOL) operating at 80 kV.
Quantitative PCR
qPCR was performed in a Light Cycler 480 II (Roche Diagnostics
GmbH, Mannheim, Germany) using the iQ™ SYBRs Green Super-
mix (Bio Rad), according to the manufacturer's protocol. The DNA
was ampliﬁed by PCR using a forward primer from Promega
(RVprimer_pGL3), which was common to all RV and reverse
primers that were designed for each individual RV as described
in the supplementary Table S3. Speciﬁc primer pairs were
designed for pGL3-Control and the luciferase gene. The quantiﬁca-
tion of each RV in the extracted DNA samples was performed with
the Light Cycler 480 II software for an advanced relative quanti-
ﬁcation with an efﬁciency correction using standard curves for
each primer pair. The concentration of each RV was normalized to
the luciferase gene and was expressed as a proportion of the
individual vector in the total amount of DNA.
Replication assay and Southern blotting
The 3T3 cells that were transfected with individual vectors by
nucleofection were harvested at 48 h post-transfection for the
extraction of total DNA. The DNA from each sample (0.5 μg) was
digested with Sal I and Dpn I enzymes, separated by electrophor-
esis in 0.8% agarose and blotted onto a nylon membrane (Roche
Diagnostics GmbH, Mannheim, Germany). Southern blotting was
performed with a DIG High Prime DNA Labeling and Detection
Starter Kit II (Roche Diagnostics GmbH, Mannheim, Germany)
according to the manufacturer's protocol. The hybridization was
performed using a DIG-labeled probe that contained the luciferase
gene probe. The blots were detected with chemiluminescence and
were recorded by exposure to X-ray ﬁlm. The optical densities of
the bands were determined with a GS-800™ Calibrated Densit-
ometer (Bio-Rad Laboratories, Hercules, California, USA).
Immunoﬂuorescence
The cells that were grown on the glass slides were ﬁxed in 3.7%
paraformaldehyde (PFA) in PBS for 15 min, permeabilized with
0.5% Triton X-100 in PBS for 5 min, rinsed 3 times with PBS and
blocked with PBS containing 0.25% bovine serum albumin and
0.25% porcine skin gelatin for 30 min. Immunostaining with
primary and secondary antibodies was performed for 1 h and
30 min, respectively, with extensive washing by PBS after each
incubation step. The cells were mounted in 50% glycerol with 40,6-
diamidino-2-phenylindole (DAPI) and were examined using an
Olympus BX-60 ﬂuorescence microscope (Olympus; Center Valley,
Pennsylvania, USA).
Antibodies
The following primary antibodies were used: rat monoclonal
IgG against the MPyV large T-antigen (LT1) (Dilworth and Grifﬁn,
1982), mouse monoclonal anti-MPyV VP1 IgG, mouse monoclonal
IgG against the common region of VP2 and VP3 (Forstová et al.,
1993) and the goat anti-luciferase polyclonal antibody (pAb)
(Promega, Madison, Wisconsin, USA). The following secondary
antibodies were used: donkey anti-mouse IgG and donkey anti-rat
IgG conjugated with Alexa Fluor 488, goat anti-rat and donkey
anti-goat IgGs conjugated with Alexa Fluor 546 and chicken
anti-mouse IgG conjugated with Alexa Fluor 647 (all from Mole-
cular Probess, Invitrogen, Paisley, UK).
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